A multicenter, retrospective study to investigate the effect of long-term Imatinib treatment in Japanese patients with advanced, unresectable or recurrent gastrointestinal stromal tumors.
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2015
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 28 Nov 2015 New trial record